Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas

Radiotherapy and Oncology

Volumn 76, Issue 2, 2005, Pages 213-218

  Hoogsteen, Ilse J ^a   Peeters, Wenny J M ^a   Marres, Henri A M ^a   Rijken, Paul F J W ^a   Van Den Hoogen, Franciscus J A ^a   Van Der Kogel, Albert J ^a   Kaanders, Johannes H A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Erythropoietin; Erythropoietin receptor; Head and neck cancer; Hypoxia

Indexed keywords

ERYTHROPOIETIN RECEPTOR; PARAFFIN; PIMONIDAZOLE;

ADULT; ADVANCED CANCER; AGED; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; STAINING; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NITROIMIDAZOLES; RECEPTORS, ERYTHROPOIETIN; SURVIVAL RATE;

EID: 28444437663     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.06.030     Document Type: Conference Paper

References (20)

1. G. Acs, M. Chen, X. Xu, P. Acs, A. Verma, and C.J. Koch Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells Cancer Lett 214 2004 243 251
2. G. Acs, P.J. Zhang, and C.M. McGrath Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression Am J Pathol 162 2003 1789 1806
3. M.O. Arcasoy, K. Amin, S.C. Chou, Z.A. Haroon, M. Varia, and J.A. Raleigh Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia Clin Cancer Res 11 2005 20 27
4. M.O. Arcasoy, K. Amin, and A.F. Karayal Functional significance of erythropoietin receptor expression in breast cancer Lab Invest 82 2002 911 918
5. J. Bohlius, S. Langensiepen, and G. Schwarzer Erythropoietin for patients with malignant disease (review) Cochrane Library 1 2005 1 155
6. A.D. D'Andrea, and L.I. Zon Erythropoietin receptor. Subunit structure and activation J Clin Invest 86 1990 681 687
7. A.L. Harris Hypoxia - a key regulatory factor of in tumour growth Nat Rev Cancer 2 2002 38 47
8. M. Henke, R. Laszig, and C. Rübe Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomized, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260
9. P.J. Hoskin, A. Sibtain, F.M. Daley, M.I. Saunders, and G.D. Wilson The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma Radiother Oncol 72 2004 159 168
10. J.H.A.M. Kaanders, and A.J. van der Kogel Erythropoietin to treat anaemia in patients with head and neck cancer Lancet 363 2004 78 79
11. J.H.A.M. Kaanders, L.A.M. Pop, and H.A.M. Marres ARCON: experience in 215 patients with advanced head-and-neck cancer Int J Rad Oncol Biol Phys 52 2002 769 778
12. J.H.A.M. Kaanders, K.I.E.M. Wijffels, and H.A.M. Marres Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Res 62 2002 7066 7074
13. S.B. Krantz Erythropoietin Blood 77 1991 419 434
14. C. Lacombe, and P. Mayeux The molecular biology of erythropoietin Nephrol Dial Transplant 14 1999 22 28
15. B. Leyland-Jones, and BEST Investigators and Study Group Breast cancer trial with erythropoietin terminated unexpectedly Lancet Oncol 4 2003 459 460
16. M. Nordsmark, J. Loncaster, and C. Aquino-Parsons Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas Radiother Oncol 67 2003 35 44
17. V. Rosti, P. Pedrazolli, and L. Ponchio Effect of recombinant human erythropoietin on hematopoietic and non-hematopoietic malignant cell growth in vitro Haematologica 78 1993 208 212
18. G. Stüben, O. Thews, C. Pöttgen, K. Knühmann, P. Vaupel, and M. Stutschke Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice J Cancer Res Clin Oncol 127 2001 346 350
19. P. Vaupel, A. Mayer, and M. Höckel Tumor hypoxia and malignant progression Methods Enzymol 381 2004 335 354
20. K.J. Williams, B.A. Telfer, and D. Xenaki Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1 Radiother Oncol 75 2005 89 98